Royal Bank of Canada’s CME Group CME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-10,000
Closed -$1.82M 7453
2020
Q4
$1.82M Hold
10,000
﹤0.01% 3001
2020
Q3
$1.67M Hold
10,000
﹤0.01% 2840
2020
Q2
$1.63M Hold
10,000
﹤0.01% 2797
2020
Q1
$1.73M Hold
10,000
﹤0.01% 2599
2019
Q4
$2.01M Hold
10,000
﹤0.01% 2872
2019
Q3
$2.11M Hold
10,000
﹤0.01% 2708
2019
Q2
$1.94M Hold
10,000
﹤0.01% 2800
2019
Q1
$1.65M Buy
+10,000
New +$1.77M ﹤0.01% 2844

Other funds holding CME

Royal Bank of Canada's CME Position: Q1 2026 in Review

Royal Bank of Canada reduced its CME Group (CME) stake by 10% in Q1 2026, selling an estimated $97.7M and leaving 2,950,082 shares worth $871M. The position accounts for 0.15% of the portfolio, ranked #131.

Royal Bank of Canada first reported a position in CME in Q2 2013 and has held it in 52 quarters since. The position peaked at $939M in Q2 2025. 1,793 funds tracked by Wall St. Rank hold CME as of Q1 2026.

  • Royal Bank of Canada held 2,950,082 shares of CME Group worth $871M as of Q1 2026.
  • Royal Bank of Canada sold 328,873 CME Group shares in Q1 2026, an estimated $97.7M.
  • CME Group made up 0.15% of Royal Bank of Canada's portfolio in Q1 2026, its #131 holding.
  • Royal Bank of Canada first reported a position in CME Group in Q2 2013 and has held it in 52 quarters since.
  • Royal Bank of Canada's CME Group position peaked at $939M in Q2 2025.
  • 1,793 funds tracked by Wall St. Rank held CME Group as of Q1 2026.

Based on Royal Bank of Canada's 13F filing for Q1 2026, filed 15 May 2026.